Impax Laboratories, Inc. announced this week that the United States Food and Drug Administration (FDA) has approved the Company’s supplemental new drug application (sNDA) for EMVERM (mebendazole)...

Infectious disease outbreaks that turn into epidemics or pandemics can kill millions of people and cause trillions of dollars of damage to economic activity, says a new report from the international, independent...

By

In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin...

By

Merck yesterday announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) therapy,...

By

Health Canada is advising Canadians that the use of over-the-counter acne products applied to the skin containing benzoyl peroxide or salicylic acid may cause rare but serious allergic reactions. Signs...

By

A novel class of antimicrobials that inhibits the function of a key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the...

By

The U.S. Food and Drug Administration Tuesday approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer...

By

Approximately 1 in 4 gay, bisexual men; 1 in 5 people who inject drugs; and 1 in 200 heterosexuals should be counseled about pre-exposure prophylaxis (PrEP) A new CDC  Vital Signs report published Tuesday...

By

Earlier this week,  the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or...

By

Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy. Multiple...